Orilissa (generic elagolix) is a drug from AbbVie Inc. and Neurocrine Biosciences, approved by the FDA in the summer of 2018, and prescribed for women with moderate to severe endometriosis pain. Endometriosis is a chronic disease in which uterine lining tissue grows outside the uterus. The drug shuts down the hormonal cycle, stopping the monthly menstrual period. It is currently being heavily advertised, with a list price of approximately $850 per month.
It caught our attention because some of the serious side effects are suicidal thoughts, actions, or behavior, and worsening of mood.
The prescribing information advises that patients with new or worsening depression, anxiety or other mood changes should be referred to a mental health professional. We urge caution, because a psychiatrist may misdiagnose such symptoms as a mental disorder rather than a drug side effect, and prescribe harmful psychotropic drugs instead of properly handling the side effects.
Suicidal ideation and behavior, including one completed suicide, occurred in subjects treated with Orilissa in the endometriosis clinical trials. Users had a higher incidence of depression and mood changes compared to placebo. Some of the most common adverse reactions in clinical trials included anxiety, depression and mood changes.
The drug is a gonadotropin-releasing hormone antagonist, which means it blocks the receptors of certain hormones in the brain’s pituitary gland, leading to the suppression of luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone. Patients are advised to limit the duration of use because of bone loss; bone mineral density loss is greater with increasing duration of use and may not be completely reversible.
The drug is metabolized in the liver by cytochrome P450 enzymes, so a person genetically deficient in these enzymes, or who is taking other drugs that inhibit CYP450 enzymes, is at risk of a toxic accumulation of the drug leading to more severe side effects.
There does not appear to be any scientific data about exactly why suicidality and behavior changes are potential adverse reactions, but we might surmise that messing with hormones in the brain is not exactly a well-known precision science.
The major issue we see is that mood changes as a side effect from Orilissa are likely to be misdiagnosed. Since psychiatrists do not perform clinical tests and are wont to prescribe an antidepressant rather than get to the root of the problem, we want to be sure every candidate for this drug understands the issue and practices full informed consent to any psychiatric treatment.
REXULTI (generic brexpiprazole) is a prescription psychiatric drug from Otsuka Pharmaceutical Company and Lundbeck pharmaceutical company. Although it failed Phase II clinical trials for attention-deficit hyperactivity disorder (ADHD), it was approved by the U.S. Food and Drug Administration (FDA) in 2015 as an atypical antipsychotic and prescribed for the fake “disease” schizophrenia.
Then in 2018 the FDA approved it to treat symptoms of depression when antidepressants alone do not relieve symptoms.
The cost for Rexulti oral tablet 0.25 mg is around $1,166 for a supply of 30 tablets. It has similarities to Abilify, and apparently it was developed to replace Abilify when that drug’s patent expired in 2014.
Brexpiprazole affects the levels of the neurotransmitters dopamine and serotonin in the brain. It is thought to reduce dopamine output when dopamine concentrations are high and increase dopamine output when dopamine concentrations are low. It also activates serotonin receptors to increase serotonin levels in a manner thought to reduce hallucinogenic effects, which is a problem with all drugs that mess with serotonin in the brain.
The metabolism of the drug — that is, the mechanism which eventually eliminates it from the body — is mediated by Cytochrome P450 enzymes; people who are known poor metabolizers, i.e. those with a genetic lack of these enzymes, should be instructed to take half the usual dose, although this is rarely done, since the patient must first be tested for this genetic condition. It is estimated that 10% of Caucasians and 7% of African Americans are Cytochrome P450 deficient. The consequences for someone with this deficiency who takes this drug are an increased risk for the accumulation of the non-metabolized drug in the body and the resultant increase in adverse side effects such as depression, violence and suicide.
Drugs like Rexulti can raise the risk of death in the elderly, and it is not approved for the treatment of patients with dementia-related psychosis. This drug may also increase suicidal thoughts or actions in some children, teenagers, or young adults within the first few months of treatment. It is not approved for the treatment of people younger than 18 years of age.
Rexulti may cause other serious side effects, including: compulsive, uncontrollable behaviors such as gambling, shopping, binge eating and sex (the same as with Abilify); stroke in elderly people; Neuroleptic Malignant Syndrome; high fever; stiff muscles; confusion; sweating; changes in pulse, heart rate, or blood pressure; high blood sugar (hyperglycemia); weight gain; seizures; difficulty swallowing; uncontrolled body movements known as tardive dyskinesia. Tardive dyskinesia may not go away, even after one stops taking the drug, and tardive dyskinesia may also start some time after one stops taking the drug.
The real problem is that psychiatrists fraudulently diagnose life’s problems as an “illness”, and stigmatize unwanted behavior as “diseases.” Psychiatry’s stigmatizing labels, programs and treatments are harmful junk science; their diagnoses of “mental disorders” are a hoax – unscientific, fraudulent and harmful. All psychiatric treatments, not just psychiatric drugs, are dangerous. Find Out! Fight Back!
We often remark on serotonin when discussing psychiatric drugs, so we thought we’d describe it in more depth.
The word comes from the combination of sero- (serum) + tonic (from Greek tonos string or stretching) + -in (from Latin -ina a term used to form words). It was first named in 1948, although its effects had likely been observed since 1868.
Serotonin is a neurotransmitter hormone synthesized in the adrenal glands and elsewhere in the body from the essential amino acid tryptophan (chemical formula C10H12N2O, also called 5-hydroxytryptamine), found in the brain, blood, and mostly the digestive tract, which allows nerve cells throughout the body to communicate and interact with each other.
Some of its effects include: — helping smooth muscles to contract, such as the abdominal muscles that aid digestion, — helping to regulate expansion and contraction of blood vessels, — assisting the clotting of blood to close a wound, — helping to regulate mood, aggression, appetite, and sleep.
It helps to create a sense of well-being or comfort in the body, which is the starting point for the theory of using it as an antidepressant.
Since serotonin impacts every part of your body, messing with it can cause unwanted and dangerous side effects. Obviously, the body must closely regulate and balance the level of serotonin, since both a deficiency or an excess can be harmful.
It is mainly metabolized in the liver and the resulting products are excreted by the kidneys.
It is also found in animals, insects, fungi and plants.
Extremely high levels of serotonin can cause a condition known as serotonin syndrome, with toxic and potentially fatal effects. It can be caused by an overdose of drugs or interactions between drugs which increase the concentration of serotonin in the central nervous system, the most common of which are the selective serotonin reuptake inhibitors (SSRIs), whose purpose is to raise the level of serotonin in the brain.
A toxic level of serotonin can occur by taking two or more of these types of drugs, even if each is only a normal therapeutic dose. Many drugs, both legal and illegal, influence the level of serotonin in the brain — including some antidepressants, appetite suppressants, analgesics (pain drugs), sedatives, antipsychotics, anti-anxiety drugs, antimigraine drugs, antiemetics (for relief of nausea and vomiting), antiepileptics, cannabis (marijuana), LSD, MDMA (Ecstasy), psilocybin (the active ingredient in magic mushrooms), and cannabidiol (CBD).
There aren’t any tests that can diagnose serotonin syndrome. Instead, one has to observe the extent and severity of the various adverse reactions. Some side effects of serotonin syndrome can be altered mental status, muscle twitching, confusion, high blood pressure, fever, restlessness, sweating, tremors, shivering, or death.
Some people have a genetic defect with cytochrome P450 enzymes which influences serotonin metabolism. Some research also suggests that the interactions of psychotropic drugs with cytochrome P450 in the brain may also influence serotonin metabolism. Basically, these interactions can be extremely complex, and the results are unpredictable — meaning that wild variations in serotonin concentration, both lower and higher than optimum, may occur, with the attendant adverse reactions.
The proponents of all these drugs basically ignore the fact that they mess with serotonin when making claims for safety and usefulness. Messing with neurotransmitters in the brain without totally understanding how they work is serious business. Researchers know that 60 to 70 percent of patients diagnosed with depression continue to feel depressed even while taking such drugs. There is still a lot unknown about such interactions and long term safety, so caution is definitely advised.
An article in the October, 2018 print issue of Scientific American (“Postpartum Relief” on page 22) makes an interesting point, saying, “Many women who suffer from postpartum depression receive standard antidepressants, including selective serotonin reuptake inhibitors such as Prozac. It is unclear how well these drugs work, however, because the neurotransmitter serotonin may play only a secondary role in the condition or may not be involved at all.” (Emphasis ours.)
Researchers still only conjecture about any relationship between depression and serotonin, and they are coming to understand that the results do not support the hype.
Psychiatrists have known since the beginning of psychopharmacology that their drugs do not cure any disease. Further, there is no credible evidence that depression is genetic or linked to serotonin transport; these are just public relations theories to support the marketing and sale of drugs. The manufacturers of every such drug state in the fine print that they don’t really understand how it works. Psychiatric drugs are fraudulently marketed as safe and effective for the sole purpose of earning billions for the psycho-pharmaceutical industry.
These drugs mask the real cause of problems in life and debilitate the individual, so denying him or her the opportunity for real recovery and hope for the future. This is the real reason why psychiatry is a violation of human rights. Psychiatric treatment is not just a failure — it is routinely destructive to the individual and one’s mental health.
This report was prepared in 2018 by the U.S. Senate Homeland Security & Governmental Affairs Committee Minority Office as requested by Senator Claire McCaskill of Missouri.
It examines the history of rising drug prices between 2012 and 2017 for the twenty brand-name drugs most commonly prescribed for seniors.
Drugs were identified using data from Medicare Part D, and average prices were statistically calculated to come up with annual weighted average wholesale acquisition costs.
Of the twenty drugs in the report, two are used off-label for psychiatric purposes: §Lyrica (pregabalin), approved for controlling epileptic seizures and neuropathic pain, is also used off-label as an anti-anxiety drug; it carries a warning that it may cause suicidal thoughts or actions.
§ Synthroid (levothyroxine), a synthetic thyroid hormone approved for hypothyroidism, is also used off-label as an antidepressant, although a specific, causally significant hormonal deficiency has not been identified for depression; it has potential side effects of hair loss, mental and mood changes such as depression, easily broken bones, heart problems, and seizures.
A Lyrica prescription rose in average cost between 2012 and 2017 from $264 to $600 (a 127% increase), while the number of prescriptions rose from 9.1 million to 10.3 million (a 14% increase).
A Synthroid prescription rose in average cost between 2012 and 2017 from $96 to $153 (a 60% increase), while the number of prescriptions dropped from 23.0 million to 18.4 million (a 20% drop).
The report concludes, “Soaring pharmaceutical drug prices remain a critical concern for patients and policymakers alike. Over the last decade, these significant price increases have emerged as a dominant driver of U.S. health care costs.”
Frankly, we do not have a particular bone to pick about the cost of prescription drugs; what does concern us more is the off-label use of medical drugs for fraudulent psychiatric conditions, and the seriousness of their potential side effects. If this concerns you as well, please let Senator McCaskill know your thoughts about this.
We recommend informed consent for any treatment plan. Protect yourself, your family and friends, with full informed consent. Courts have determined that informed consent for people who receive prescriptions for psychotropic (mood-altering) drugs must include the doctor providing information about possible side effects and benefits, ways to treat side effects, and risks of other conditions, as well as information about alternative treatments.
“As far back as the mid-1990s, leading psychiatrists recognized withdrawal as a potential problem for patients taking modern antidepressants.”
On the other hand, CCHR has been making this known since 1969. Psychiatrists have been loathe to admit the addictive nature of antidepressants and other psychotropic (mind-altering) drugs, and euphemistically call the side effects of withdrawing from psychiatric drugs “discontinuation syndrome”.
Drug addiction in the 1960’s became an increasing problem, and when investigated it was found that psychiatrists were pushing drugs and addicting people as a “cure.”
“Long-term use of antidepressants is surging in the United States, according to a new analysis of federal data by The New York Times. Some 15.5 million Americans have been taking the medications for at least five years. The rate has almost doubled since 2010, and more than tripled since 2000.”
Nearly 25 million adults have been on antidepressants for at least two years, a 60 percent increase since 2010.
“Many who try to quit say they cannot because of withdrawal symptoms they were never warned about.”
We recommend Informed Consent. Protect yourself, your family and friends, with full informed consent. Courts have determined that informed consent for people who receive prescriptions for psychotropic (mood-altering) drugs must include the doctor providing information about possible side effects and benefits, ways to treat side effects, and risks of other conditions, as well as information about alternative treatments.
“Antidepressants are not harmless; they commonly cause emotional numbing, sexual problems like a lack of desire or erectile dysfunction and weight gain.”
“Patients who try to stop taking the drugs often say they cannot. In a recent survey of 250 long-term users of psychiatric drugs — most commonly antidepressants — about half who wound down their prescriptions rated the withdrawal as severe. Nearly half who tried to quit could not do so because of these symptoms.”
“The truth is that the state of the science is absolutely inadequate … We don’t have enough information about what antidepressant withdrawal entails, so we can’t design proper tapering approaches.”
Polypharmacy is another significant problem, wherein a patient is prescribed many, possibly negatively-interacting drugs, often by multiple doctors who might be unaware of each other’s prescription orders. Often, these are drugs that the patient has been taking for a long period; they may be affecting the patient’s health negatively or are simply no longer beneficial. This is often addressed by deprescribing, which is the process of reducing the medication burden of a patient who might no longer need one or more of their prescriptions. Deprescribing principles are intended to improve health care for the patient by minimizing the harm and costs associated with polypharmacy, and minimizing the withdrawal effects of stopping one or more drugs.
Medications that may be considered for discontinuation include drugs that are no longer indicated, drugs that pose a risk for untoward side effects, drugs that interact adversely, drugs that are given to mitigate the side effects of another drug, and addictive drugs that have withdrawal side effects. However, addictive drugs should never be discontinued abruptly, since the withdrawal side effects can be severe.
If you want happiness for an hour — take a nap. If you want happiness for a day — go fishing. If you want happiness for a year — inherit a fortune. If you want happiness for a lifetime — help someone else. [Chinese Proverb]
What is happiness, really? Is it “happy pills?” Mother’s little helper? Is “happiness” the opposite of “depression,” so that an anti-depressant should make one happy? Unfortunately, what anti-depressants do is actually detach one from reality; and the only happiness accrues to pharmaceutical companies who rake in $80 billion a year worldwide for psychiatric drugs.
As is usual with English words, “happiness” has more than one definition: 1) transient pleasure; 2) overcoming not unknowable obstacles toward a known goal; 3) a condition or state of well-being, contentment, pleasure; 4) joyful, cheerful, untroubled existence; 5) the reaction to having nice things happen to one.
Psychiatry, however, redefines happiness as a manic or hypomanic indication (associated with a bipolar diagnosis) which occurs in 14 separate entries in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5.)
Manic: characterized by frenetic activity or wild excitement; excitement of psychotic proportions manifested by mental and physical hyperactivity, disorganization of behavior and elevation of mood. Hypomanic: A mild form of mania, marked by elation and hyperactivity; a mood state characterized by persistent dis-inhibition and pervasive euphoria.
“Treatment” generally includes psychotropic mood stabilizers, unless the state is a result of drug abuse or drug side effects — in which case the “treatment” may include psychotropic sedatives. All of these psychotropic drugs are addictive, mess up the central nervous system, and can have many disastrous side effects including violence and suicide.
For more information about mood stabilizers such as Lithium, Depakote (sodium valproate), Depakene (sodium valproate), Lamictal (lamotrigine), Lamictin (lamotrigine), Lamogine (lamotrigine); download and read the booklet Mood Stabilizers — the facts about the effects.
One psychologist even overtly proposed happiness as a psychiatric disorder. [From the website of the National Center for Biotechnology Information, U.S. National Library of Medicine, a division of the National Institutes of Health]. One might think this was an April Fool’s joke, except that it was published in June.
Published in the Journal of Medical Ethics – J Med Ethics. 1992 Jun;18(2):94-8 “A proposal to classify happiness as a psychiatric disorder” Richard P Bentall, Professor of Clinical Psychology at the University of Liverpool in the UK:
“It is proposed that happiness be classified as a psychiatric disorder and be included in future editions of the major diagnostic manuals under the new name: major affective disorder, pleasant type. In a review of the relevant literature it is shown that happiness is statistically abnormal, consists of a discrete cluster of symptoms, is associated with a range of cognitive abnormalities, and probably reflects the abnormal functioning of the central nervous system. One possible objection to this proposal remains–that happiness is not negatively valued. However, this objection is dismissed as scientifically irrelevant.”
We think we can safely say this psychologist’s attitude is a misanthropic manifestation; the DSM-5 might call it “Adult antisocial behavior”, “Antisocial personality disorder”, or maybe just “Unspecified anxiety disorder”.
It is true that a euphoric condition is often associated with certain hallucinogenic drugs. We wouldn’t actually call that “happiness”, however; and the mania associated with many psychiatric drugs is not sustainable.
What would promote happiness is an actual cure for mental distress. The psychiatric industry itself admits it has no capacity to cure. We generally take cure to mean the elimination of some unwanted condition by some effective treatment. The primary purpose of any mental health treatment must be the therapeutic care and treatment of individuals who are suffering emotional disturbance. The only effective measure of this treatment must be “patients recovering and being sent, sane, back into society as productive individuals.” This, we would call a cure.
While it is illegal for FDA-regulated products to make cure claims, there are in fact many non-drug and non-psychiatric alternatives which may prove effective in handling traumatic conditions. The trick is in finding out what is really wrong and fixing that, not just suppressing the central nervous system with drugs so that one does not feel the bad emotions.
The sudden realization that someone might actually enjoy one’s company is a better antidepressant than anything one could get on a prescription. [With thanks to Charles Stross, The Atrocity Archive.]
Psychiatry is heavily pushing false data about depression. You should know exactly what psychiatry and psychiatrists are:
Psychiatry is an antisocial enemy of the people.
Psychiatrists are undesirable antisocial elements.
What exactly is “depression?” The dictionary has this to say about what “depression” means:
A condition of feeling sad, despondent, hopeless, or inadequacy; A reduction in physiological vigor or activity such as fatigue.
The fact is, the American Psychiatric Association, the American Medical Association and the National Institute of Mental Health admit that there are no medical tests to confirm mental disorders as a disease but do nothing to counter the false idea that these are biological/medical conditions when in fact, diagnosis is simply done by a checklist of behaviors.
Yes, people experience symptoms of depression. This does not make them “mentally diseased” and there is no evidence of physical/medical abnormality for the so-called diagnosis of “depression.” This doesn’t mean that there aren’t solutions for people experiencing difficulty; there are non harmful, medical alternatives. But they do not require a psychiatric “label” to treat them. There is no mental illness test that is scientifically/medically proven. This isn’t a matter of opinion — psychiatrists who are opposed to the labeling of behaviors as mental illness openly admit this.
There are understandable possibilities for someone experiencing symptoms of depression. One is an undiagnosed and untreated medical condition that presents mental symptoms; and there are many of these medical conditions, requiring a full and searching clinical examination by a competent medical—not psychiatric—doctor to find the underlying undiagnosed and untreated physical problem. Go to this site for examples of medical conditions which can have mental symptoms. These all have non-psychiatric-drug alternatives. A second possibility arises from stress, which is actually a situation in which a person is being suppressed in some area of their life — meaning there is something in their life, such as an antisocial person or element, which is putting them down, stopping them from getting better, invalidating or making less of one or one’s efforts.
Another possibility is simply a life event, such as grief, which has occasioned sadness or fatigue.
In the news now is a major source of false information about depression. Google is promoting this false information by teaming up with the National Alliance for Mental Illness to present a questionnaire to people who search for the word “depression” to recognize if what they are feeling is what psychiatrists call “clinical depression.” Don’t be fooled; this is simply an attempt to funnel vulnerable people into the mental health care system and prescribe them harmful and addictive psychiatric drugs. This questionnaire takes about five minutes to complete, and is just a list of behaviors, or as Dr. Thomas Szasz said, “The term ‘mental illness’ refers to the undesirable thoughts, feelings, and behaviors of persons.” More properly, it is just what psychiatry and psychiatrists have inappropriately labeled as “undesirable behavior;” the prime undesirable antisocial people on the planet telling you what they think is undesirable!
This questionnaire has no clinical value, using ten questions such as “Over the last 2 weeks, how often have you been bothered by feeling down, depressed, or hopeless?” or do you have “trouble falling or staying asleep?” If you are logged in to Google while taking this questionnaire you will be sharing this information about yourself with Google.
The drug Ketamine is now being advertised as a “treatment” for “depression.” Don’t be fooled; this drug is serious business.
Ketamine, categorized as a “dissociative anesthetic,” is used in powdered or liquid form as an anesthetic, on animals as well as people. It can be injected, consumed in drinks, snorted, or added to joints or cigarettes.
By “dissociative anesthetic” we mean that this drug distorts perception of sight and sound and produces feelings of detachment (dissociation) from the environment and self.
Short- and long-term effects include increased heart rate and blood pressure, nausea, vomiting, numbness, depression, amnesia, hallucinations and potentially fatal respiratory problems. Ketamine users can also develop cravings for the drug. At high doses, users experience an effect referred to as “K-Hole,” an “out of body” or “near-death” experience.
Due to the detached, dreamlike state it creates, where the user finds it difficult to move, ketamine has been used as a “date-rape” drug. The increase in illicit use prompted ketamine’s placement in Schedule III of the United States Controlled Substance Act in August 1999.
[Update 9/5/2018 from Consumer Reports] “All these drugs [Ketamine, Phenylbutazone, Chloramphenicol] are prohibited in beef, poultry, and pork consumed in the U.S. Yet government data obtained by Consumer Reports suggest that trace amounts of these and other banned or severely restricted drugs may appear in the U.S. meat supply more often than was previously known.”
Ketamine is being promoted as an intravenous treatment for depression by an anesthesiologist in the St. Louis area. It does not cure anything, any effect it does have is of short duration, and must be administered on a regular basis to have a continuing effect. Its actual mechanism of operation is not well understood, but one can see that as an anesthetic it simply reduces ones general awareness, so the awareness of one’s depressive thoughts are suppressed. These return once the drug wears off.
Note that “depression” is not an actual medical illness; it is simply a symptom of some undiagnosed and untreated condition.
Currently, ketamine is not approved for the treatment of depression, and so this is an off-label use. Ketamine use as a recreational drug has been implicated in deaths globally. 10% to 20% of patients at anesthetic doses experience adverse reactions.
Its use to treat so-called depression is unethical and actually harmful, since it precludes the patient from finding out what is actually wrong and getting that treated.
According to the New York Daily News, Alexander Bonds who killed Officer Miosotis Familia as she sat inside a parked police vehicle on July 5, was likely taking psychiatric drugs known to cause violence and suicide. Bonds was shot to death by police after the killing of NYPD veteran Familia as she worked a midnight tour in the Bronx.
Here are the quotes:
“…Alexander Bonds spent eight hours at a Bronx hospital after appearing for a impromptu psychiatric exam just four days before he executed an NYPD officer.” “…an NYPD search of the ex-con’s squalid South Bronx apartment turned up prescription anti-psychotic and anti-depressant drugs…” “The anti-psychotic was Risperidone, typically used to treat schizophrenia and bipolar disorder, while the anti-depressants were identified as Bupropion and Escitalopram…” “In an interview after the execution, the girlfriend told police that Bonds visited a psychiatrist last month…” “Police investigators also found Benadryl and a muscle relaxant in Bonds’ second floor apartment…”
All of the listed psychiatric drugs have the potential adverse side effects of violent and suicidal behavior. Risperidone is an antipsychotic, also called a neuroleptic (“nerve seizing”). Bupropion is an antidepressant (norepinephrine-dopamine reuptake inhibitor.) Escitalopram is an antidepressant (selective serotonin reuptake inhibitor.) Benadryl is an antihistamine that interacts moderately with risperidone and buproprion and excitalopram, meaning that there is an increased risk of adverse side effects when taken together.
The FDA has issued several warnings on these psychotropic drugs, cautioning that persons prescribed the drugs must be monitored for increased suicidal ideation and worsening depression.
The bottom line is — Check for psychiatric treatment and psychiatric drugs (prior or current use, or withdrawal from) in all cases of senseless violence.
The psycho-pharmaceutical industry has jumped full-time onto the climate change bandwagon. You don’t even need to believe in climate change, since there is also the satirical “Climate Change Denial Disorder”.
Scholarly articles are being published claiming that climate change affects mental health, along with the typical cries to fund more research, prescribe more antidepressants, and prepare for the worst. Here is an example quote: “Increasing ambient temperatures is likely to increase rates of aggression and violent suicides, while prolonged droughts due to climate change can lead to more number of farmer suicides. … Increased frequency of disasters with climate change can lead to posttraumatic stress disorder, adjustment disorder, and depression.” [Mental health effects of climate change, Indian J Occup Environ Med. 2015 Jan-Apr; 19(1): 3–7.]
The DSM-5 does not lack for possible disorders that can be tied to some climate change disaster for which antidepressants can be prescribed. Here are a few:
“Disruptive mood dysregulation disorder” “Other specified trauma- and stressor-related disorder” “Unspecified trauma- and stressor-related disorder” “Specific phobia, Natural environment” “Posttraumatic stress disorder” or any one of over thirty depression-related disorders.
It used to be called “Seasonal Affective Disorder” (SAD). Although this is no longer classified as a unique disorder, it can still be diagnosed as a “mood disorder with a seasonal pattern.” SAD is considered a subtype of major depression or bipolar disorder. An example of a SAD diagnosis might be “Major Depressive Disorder, Recurrent Episode, Moderate, With Seasonal Pattern”.
Here we have the “dangerous environment” in full bloom. A dangerous environment only persists if we fail to spread a safe environment across the world. What makes a dangerous environment? Confusion, conflict and upset.
The Merchants of Chaos who promote a dangerous environment make it seem as threatening as possible so that they can profit from it. How do you counter this? You spread the truth. Behind the truth comes the calm. You may still need technology to handle climate change, but you don’t need antidepressant drugs to do so.
The issue is not “is there or is there not climate change?” The issue is, get rid of the psychiatrists who are promoting and profiting from the confusion. Find Out! Fight Back!